|
RHOA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.048000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.955800E-02 |
| Normal-vs-Stage2 |
1.004750E-01 |
| Normal-vs-Stage3 |
4.200000E-02 |
| Normal-vs-Stage4 |
1.822830E-01 |
| Stage1-vs-Stage2 |
4.568400E-01 |
| Stage1-vs-Stage3 |
5.556000E-01 |
| Stage1-vs-Stage4 |
9.318600E-01 |
| Stage2-vs-Stage3 |
7.722200E-01 |
| Stage2-vs-Stage4 |
6.236400E-01 |
| Stage3-vs-Stage4 |
7.408800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.182000E-02 |
| Normal-vs-AfricanAmerican |
9.410000E-01 |
| Normal-vs-Asian |
7.171400E-01 |
| Caucasian-vs-AfricanAmerican |
2.050000E-01 |
| Caucasian-vs-Asian |
2.610200E-01 |
| AfricanAmerican-vs-Asian |
7.529200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.764000E-02 |
| Normal-vs-Female |
4.432200E-02 |
| Male-vs-Female |
7.315600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.159600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.150400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.241900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.903600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.396800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.478000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.613000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.114220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.817600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.301000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.378400E-01 |
| Classical-VS-Follicular |
3.965000E-04 |
| Classical-VS-Other |
8.025700E-02 |
| Classical-VS-Normal |
4.133800E-01 |
| Tall-VS-Follicular |
1.814140E-02 |
| Tall-VS-Other |
1.147180E-01 |
| Tall-VS-Normal |
4.492200E-01 |
| Follicular-VS-Other |
7.969800E-01 |
| Follicular-VS-Normal |
3.804000E-04 |
| Other-VS-Normal |
1.462630E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.684500E-03 |
| Normal-vs-N1 |
1.257580E-03 |
| N0-vs-N1 |
1.600840E-01 |
|
|
